FI894520A - Menetelmä terapeuttisesti aktiivisten 8-aminosubstituoitu-7,8-dihydro-6,6-dimetyyli-6H-pyrano/2,3-f/bentso-2,1,3-oksadiatsolien valmistamiseksi - Google Patents

Menetelmä terapeuttisesti aktiivisten 8-aminosubstituoitu-7,8-dihydro-6,6-dimetyyli-6H-pyrano/2,3-f/bentso-2,1,3-oksadiatsolien valmistamiseksi Download PDF

Info

Publication number
FI894520A
FI894520A FI894520A FI894520A FI894520A FI 894520 A FI894520 A FI 894520A FI 894520 A FI894520 A FI 894520A FI 894520 A FI894520 A FI 894520A FI 894520 A FI894520 A FI 894520A
Authority
FI
Finland
Prior art keywords
pyrano
oxadiazoles
benzo
dihydro
dimethyl
Prior art date
Application number
FI894520A
Other languages
English (en)
Swedish (sv)
Other versions
FI894520A0 (fi
FI90240B (fi
FI90240C (fi
Inventor
Seto Kiyotomo
Matsumoto Hiroo
Kamikawaji Yoshimasa
Ohrai Kazuhiko
Nakayama Koyko
Sakoda Ryozo
Masuda Yukinori
Original Assignee
Nissan Chemical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Ind Ltd filed Critical Nissan Chemical Ind Ltd
Publication of FI894520A0 publication Critical patent/FI894520A0/fi
Publication of FI894520A publication Critical patent/FI894520A/fi
Publication of FI90240B publication Critical patent/FI90240B/fi
Application granted granted Critical
Publication of FI90240C publication Critical patent/FI90240C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI894520A 1988-02-03 1989-09-25 Menetelmä terapeuttisesti aktiivisten 8-aminosubstituoitu-7,8-dihydro-6,6-dimetyyli-6H-pyrano/2,3-f/bentso-2,1,3-oksadiatsolien valmistamiseksi FI90240C (fi)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
JP2340988 1988-02-03
JP2340988 1988-02-03
JP4845888 1988-03-01
JP4845888 1988-03-01
JP7576288 1988-03-29
JP7576288 1988-03-29
JP12758488 1988-05-25
JP12758488 1988-05-25
JP8900106 1989-02-02
PCT/JP1989/000106 WO1989007103A1 (en) 1988-02-03 1989-02-02 Pyranobenzoxadiazole derivatives

Publications (4)

Publication Number Publication Date
FI894520A0 FI894520A0 (fi) 1989-09-25
FI894520A true FI894520A (fi) 1989-09-25
FI90240B FI90240B (fi) 1993-09-30
FI90240C FI90240C (fi) 1994-01-10

Family

ID=27457958

Family Applications (1)

Application Number Title Priority Date Filing Date
FI894520A FI90240C (fi) 1988-02-03 1989-09-25 Menetelmä terapeuttisesti aktiivisten 8-aminosubstituoitu-7,8-dihydro-6,6-dimetyyli-6H-pyrano/2,3-f/bentso-2,1,3-oksadiatsolien valmistamiseksi

Country Status (17)

Country Link
US (1) US4900752A (fi)
EP (1) EP0327127B1 (fi)
JP (1) JPH0699439B2 (fi)
KR (1) KR970009591B1 (fi)
AU (1) AU609244B2 (fi)
BG (1) BG50159A3 (fi)
BR (1) BR8905292A (fi)
CA (1) CA1331990C (fi)
DE (1) DE68900210D1 (fi)
DK (2) DK167533B1 (fi)
ES (1) ES2039292T3 (fi)
FI (1) FI90240C (fi)
GR (1) GR3002637T3 (fi)
HU (1) HU206117B (fi)
RU (1) RU2054007C1 (fi)
WO (1) WO1989007103A1 (fi)
ZA (1) ZA89860B (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5097037A (en) * 1989-07-17 1992-03-17 Nissan Chemical Industries, Ltd. Process for the optical resolution of pyranobenzoxadiazole compounds
GB8924373D0 (en) * 1989-10-30 1989-12-20 Beecham Group Plc Novel compounds
DE4010097A1 (de) * 1990-03-29 1991-10-02 Basf Ag Ungesaettigte n-benzoxodiazolopyranyllactame, ihre herstellung und verwendung
JPH04342591A (ja) * 1990-07-10 1992-11-30 Nissan Chem Ind Ltd ピラノベンゾオキサジアゾール誘導体
US5164509A (en) * 1990-11-26 1992-11-17 E. R. Squibb & Sons, Inc. Benzodiazolo analogs
EP0492391A3 (en) * 1990-12-26 1993-01-20 Nissan Chemical Industries Ltd. Hair growth stimulator
CA2061179A1 (en) * 1991-02-18 1992-08-19 Ryuji Tsuzuki Oxzazinobenzazole compounds
US5352814A (en) * 1991-08-30 1994-10-04 Nissan Chemical Industries, Ltd. Asymmetric epoxidation reaction
AU677643B2 (en) * 1993-04-02 1997-05-01 Nissan Chemical Industries Ltd. Heart failure remedy
KR101019402B1 (ko) * 2004-03-23 2011-03-07 닛산 가가쿠 고교 가부시키 가이샤 항부정맥제로 사용되는 삼환계 벤조피란 화합물
GB0615670D0 (en) * 2006-08-07 2006-09-13 Syngenta Participations Ag Chemical compounds
WO2011044237A1 (en) 2009-10-06 2011-04-14 Kbi Biopharma, Inc. Methods, systems and apparatus for manipulating particles

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH25238A (fr) * 1901-10-22 1903-04-30 Fredinand Rozes Jean Nouvelle chaufferette
FR1406106A (fr) * 1963-04-10 1965-07-16 Daiichi Seiyaku Co Procédé de production de composés stéroïdes du [2, 3-c]-furazane
JPS5912738Y2 (ja) * 1979-04-20 1984-04-17 オリンパス光学工業株式会社 電源接続装置
DE3064286D1 (en) * 1979-09-28 1983-08-25 Beecham Group Plc Chromanol derivatives, a process for their preparation and a pharmaceutical composition comprising them
DE3064285D1 (en) * 1979-09-28 1983-08-25 Beecham Group Plc Chromanol derivatives, a process for their preparation and a pharmaceutical composition comprising them
DE3163018D1 (en) * 1980-02-02 1984-05-17 Beecham Group Plc Pyrano derivatives, a process for their preparation and antihypertensive compositions containing them
ZM7682A1 (en) * 1981-09-25 1983-05-23 Beecham Group Plc Active compounds

Also Published As

Publication number Publication date
JPH0699439B2 (ja) 1994-12-07
DK169924B1 (da) 1995-04-03
DK1693D0 (da) 1993-01-07
ZA89860B (en) 1989-10-25
DK167533B1 (da) 1993-11-15
DE68900210D1 (de) 1991-09-26
AU2963389A (en) 1989-08-03
HU891051D0 (en) 1990-03-28
HUT56373A (en) 1991-08-28
US4900752A (en) 1990-02-13
JPH0249788A (ja) 1990-02-20
HU206117B (en) 1992-08-28
RU2054007C1 (ru) 1996-02-10
GR3002637T3 (en) 1993-01-25
FI894520A0 (fi) 1989-09-25
KR970009591B1 (ko) 1997-06-14
FI90240B (fi) 1993-09-30
BG50159A3 (en) 1992-05-15
DK1693A (da) 1993-01-07
DK486089A (da) 1989-12-01
EP0327127A1 (en) 1989-08-09
BR8905292A (pt) 1990-08-21
DK486089D0 (da) 1989-10-03
CA1331990C (en) 1994-09-13
AU609244B2 (en) 1991-04-26
ES2039292T3 (es) 1993-09-16
FI90240C (fi) 1994-01-10
WO1989007103A1 (en) 1989-08-10
KR900700487A (ko) 1990-08-13
EP0327127B1 (en) 1991-08-21

Similar Documents

Publication Publication Date Title
FI96861C (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen indolyylipyrrolijohdannaisten valmistamiseksi
FI890282A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
FI891492A (fi) Menetelmä terapeuttisesti aktiivisten bis-(hydroksimetyyli)syklobutyylipuriinien ja -pyrimidiinien valmistamiseksi
NO179584C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-acylaminotiazoler
NO178619C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive di-t-butylfenoler
NO175978C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive bis-aza-bicykliske forbindelser
NO174467C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater
NO176275C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridazinonderivater
FI895417A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 2'-halometylideeninukleosidien valmistamiseksi
FI872517A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten makrolidiyhdisteiden valmistamiseksi
NO173334C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive alkylaminoalkylenderivater 2H-1-benzopyraner
FI894520A (fi) Menetelmä terapeuttisesti aktiivisten 8-aminosubstituoitu-7,8-dihydro-6,6-dimetyyli-6H-pyrano/2,3-f/bentso-2,1,3-oksadiatsolien valmistamiseksi
FI93444B (fi) Menetelmä terapeuttisesti aktiivisten dihydropyridiinijohdannaisten valmistamiseksi
FI883672A (fi) Menetelmä terapeuttisesti käyttökelpoisten aminoalkoksifenyylijohdannaisten valmistamiseksi
NO173784C (no) Anaslogifremgangsmaate for fremstilling av terapeutisk aktive tieno-tri-azolo-diazepinderivater
NO174391C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater
FI892684A (fi) Menetelmä terapeuttisesti aktiivisten 4-okso-imidatso/1,5-a/kinoksaliinijohdannaisten valmistamiseksi
FI884660A0 (fi) Menetelmä terapeuttisesti aktiivisten 2,2-dimetyylikromeenijohdannaisten valmistamiseksi
FI893003A (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten neplanosiinijohdannaisten valmistamiseksi
NO174422C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater
NO174200C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-imino-6-polyfluoralkoksybenzotiazol-forbindelser
FI903077A0 (fi) Menetelmä valmistaa terapeuttisesti aktiivisia R(-)-3-kinuklidinolijohdannaisia
NO174203C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive
FI901883A0 (fi) Menetelmä terapeuttisesti vaikuttavien 2-substituoitujen N,N'-ditrimetoksibentsoyylipiperatsiinien valmistamiseksi
FI880190A0 (fi) Menetelmä valmistaa terapeuttisesti vaikuttavia tetrahydrofuraanijohdoksia

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: NISSAN CHEMICAL INDUSTRIES, LTD.